Table 3.

Organ-specific acute GVHD stage in patients receiving 131I-BC8/BU/CY and HLA-matched related allogeneic transplants for AML in first complete remission


Organ-specific GVHD severity stage52 ,53 

Skin, no. (%)

Liver, no. (%)

Gut, no. (%)
No acute GVHD   27 (57)   28 (61)   11 (24)  
1   4 (9)   8 (17)   27 (59)  
2   7 (15)   7 (15)   3 (7)  
3   7 (15)   2 (4)   5 (11)  
4
 
1 (2)
 
1 (2)
 
0 (0)
 

Organ-specific GVHD severity stage52 ,53 

Skin, no. (%)

Liver, no. (%)

Gut, no. (%)
No acute GVHD   27 (57)   28 (61)   11 (24)  
1   4 (9)   8 (17)   27 (59)  
2   7 (15)   7 (15)   3 (7)  
3   7 (15)   2 (4)   5 (11)  
4
 
1 (2)
 
1 (2)
 
0 (0)
 
Close Modal

or Create an Account

Close Modal
Close Modal